We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT03812393
Brief Title: Evaluating the Efficacy of Neratinib on Live Cell HER2 Signaling Transduction Analysis Positive Triple Negative Breast (FACT-2)

First Submitted : January 8, 2019
First Submitted that Met QC Criteria : January 17, 2019
First Posted : January 23, 2019

Last Update Submitted that Met QC Criteria : October 9, 2020
Last Update Posted : October 12, 2020